Endometriosis affects approximately 1.5 million women in the UK, leading to chronic pain and fatigue as tissue similar to the ...

The new drug could provide relief for around 1,000 women in England, but 1.5 million in the UK suffer with the condition ...

Bethany Backhouse was told she would require endometriosis surgery two years ago - but she is yet to be added to the waiting ...

Daily hormone combination pill is approved The National Institute for Health and Care Excellence has recommended relugolix combination therapy—a combination of relugolix, estradiol, and norethisterone ...

A new pill designed to revolutionise endometriosis treatment has been approved for use on the NHS. The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy ...

For the 1.5 million women in the UK living with endometriosis, relief may finally be on the horizon. A new pill, ...

The UK's NHS has approved a first daily pill, relugolix combination therapy, to treat endometriosis symptoms. The new medication offers hope to approximately 1,000 women annually who have not ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative option if treatments such as tranexamic acid, hormonal contraceptives, and ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily treatment approved for endometriosis, working by blocking hormones that ...